Amyloidosis Center News

ACC CardiaCast: Understanding AL and ATTR Cardiac Amyloidosis

In this Podcast, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on non-invasive means, disease course, and management of heart failure and conduction disease. Click this link to... More

Join Dr. Sanchorawala, Dr. Ruberg, and Lisa Mendelson, NP as they Present an Online Activity

Dr. Vaishali Sanchorawala, Dr. Frederick L Ruberg, and Lisa Mendelson, NP present an online activity titled: Recognizing the Face of Cardiac Amyloidosis: Patient and Provider Perspectives Regarding Diagnosis, Treatment, and Symptom Management For information on how to join in click the link below. https://cme.healio.com/cardiology/20210119/recognizing-the-face-of-cardiac-amyloidosis  

Shining a spotlight on race & ethnicity in systemic AL amyloidosis

With an increasingly more diverse profile of patients diagnosed with AL amyloidosis, there is a need to better understand how this unique disease may affect various patient groups differently. Author Andrew Staron Hematology & Oncology Clinical Fellow, Boston University Medical Center Contributing author Vaishali Sanchorawala MD, Boston University School of Medicine  

Dr. Sanchorawala speaks on ASCT in AL amyloidosis

Vaishali Sanchorawala The successful use of novel agents and data drawn from the ANDROMEDA trial (NCT03201965) is referenced as to why the utility of ASCT in AL amyloidosis may be questioned. However, Dr Sanchorawala does go on to explain how for a small patient population, ASCT is still a very useful... More